MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.61 -0.60%

-$0.09 today

Market cap
$175.71M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.17M

Average 0.09M

MDWD Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

MediWound Ltd.NASDAQ: MDWD

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses grows, but more slowly than its trailing trend

Q1 FY2026 other income / expenses of $5.01M rose 11.3% year over year, behind the +778.4% change in trailing-twelve-month other income / expenses. Sequentially, it rose 612.8% from the prior quarter.

Context

  • Other income / expenses amounted to 9.3% of revenue in FY2025, down 44.1 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +11.3% toward the trailing-twelve-month pace of +778.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.01M+612.8% QoQ
Last fiscal yearDec 2025
$1.57M+114.6% YoY
LTMMar 2026
$2.08M+778.4% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.3%——
1 year+114.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
1.57M USD
Year-over-year change
+114.6%

Other Income / Expenses vs competitors

How MDWD compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +778.4% is the highest of 9, against a peer median of -2.1%.
  • Other income / expenses amounts to 14.3% of revenue for MDWD, versus a peer median of 1965.8%.
MDWD Competitors
Other Income / Expenses for MDWD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TARAProtara Therapeutics, Inc.LTM Mar 2026$6.75M USD+12.2%+85.7%—
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 2026$4.85M USD+44.2%——
IVVDInvivyd, Inc.LTM Mar 2026$4.17M USD-16.4%-23.0%7.5%
SLSSELLAS Life Sciences Group, Inc.LTM Sep 2026$3.68M USD+270.3%+29.5%—
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 2026$2.76M USD+155.6%——
MDWDMediWound Ltd.LTM Mar 2026$2.08M USD+778.4%—14.3%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$325K USD-86.9%—1.0%
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026-$5.24M USD———
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$69.65M USD-583.2%—3924.1%
IVAInventiva S.A.FY2025-€211.38M EUR-144.8%—4715.1%
Peer median (excluding MDWD) —-2.1%+29.5%1965.8%

Competitors are the stored peer set for MDWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.76M26.5M18.69M20.22M16.96M
Cost of Revenue14.99M13.33M15.11M17.59M13.71M
Gross Profit8.77M13.17M3.58M2.63M3.25M
Gross Margin36.9%49.7%19.1%13.0%19.2%
Research & Development10.26M10.18M7.47M8.88M14.32M
Selling, General & Admin9.45M10.37M11.38M12.91M13.93M
Operating Expenses19.99M20.83M19.08M22.02M28.53M
Depreciation & Amortization1.24M1.27M1.3M1.48M1.86M
EBITDA(11.38M)(18.25M)(4.8M)(27.93M)(21.47M)
EBITDA Margin-47.9%-68.9%-25.7%-138.1%-126.6%
Operating Income(11.22M)(7.66M)(15.5M)(19.38M)(25.28M)
Operating Margin-47.2%-28.9%-83.0%-95.8%-149.1%
Interest Income11K270K2.34M2.05M1.86M
Interest Expense167K162K335K561K663K
Other Income / Expenses(2.3M)(11.86M)8.97M(10.78M)1.57M
Income Before Tax(13.52M)(19.52M)(6.53M)(30.16M)(23.71M)
Pre-Tax Margin-56.9%-73.7%-35.0%-149.2%-139.8%
Income Tax Expense27K78K185K61K169K
Net Income(13.55M)(19.6M)(6.72M)(30.22M)(23.88M)
Net Margin-57.0%-74.0%-35.9%-149.5%-140.8%
EPS (Basic)(3.48)(3.93)(0.75)(3.03)(2.10)
EPS (Diluted)(3.48)(3.93)(0.75)(3.03)(2.10)
Weighted Avg Shares3.89M4.99M9.01M9.96M11.38M
Weighted Avg Shares (Diluted)3.89M4.99M9.01M9.96M11.38M

MediWound Ltd.

NASDAQ:MDWD

Intrinsic Alpha fair value

Locked

Current Price

$13.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.